| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5574455 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 5 Pages |
Abstract
MMP-12 is related to critical CAS both symptomatic and asymptomatic, being mainly released in the late stage of plaque development. Moreover, we suggest that a specific pattern of matrix degrading enzyme inhibitors arises during the early phases of stroke.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Flavia MD, PhD, Noemi PhD, Maria MD, Danilo Professor, Maurizio Professor,